Xiamen Kingdomway Group Company

002626

CNE1000018X4

Food Processing

End-of-day quote Shenzhen S.E. Other stock markets 2026-02-06			5-day change	1st Jan Change
19.01 ^CNY	+0.05%		-0.05%	-3.55%

Jan. 07	Xiamen Kingdomway Group Company Receives New Dietary Ingredient Letter from the Food and Drug Administration	CI
25-10-24	Xiamen Kingdomway Group Company Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Xiamen Kingdomway Group's Worm Infection Drug Approved in China

Published on 09/11/2025 at 06:35 am EDT

MT Newswires

Latest news about Xiamen Kingdomway Group Company

Jan. 07	Xiamen Kingdomway Group Company Receives New Dietary Ingredient Letter from the Food and Drug Administration	CI
25-10-24	Xiamen Kingdomway Group Company Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-09-11	Xiamen Kingdomway Group's Worm Infection Drug Approved in China	MT
25-08-27	Xiamen Kingdomway Group Company Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-08-17	Xiamen Kingdomway to issue convertible bonds raising up to 1.29 bln yuan	RE
25-08-05	Xiamen Kingdomway Unit to Invest 3 Million Yuan Neutracetical JV	MT
25-05-16	Xiamen Kingdomway Group Company Appoints Xu Xiaote as Non-Independent Director	CI
25-05-06	Xiamen Kingdomway Group Company Approves Cash Dividend on Share A for the Year 2024, Payable on June 20, 2025	CI
25-04-28	Xiamen Kingdomway Group Company Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-10	Xiamen Kingdomway Group Company Proposes Final Cash Dividend for the Year 2024	CI
25-04-10	Xiamen Kingdomway Says U.S. Tariff Increase Will Not Impact Production, Operation	RE
25-04-09	Xiamen Kingdomway Group Company Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-10-27	Xiamen Kingdomway Group Company Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
24-09-24	Xiamen Kingdomway's Unit Receives Production License to Produce Inositol	MT
24-08-28	Xiamen Kingdomway Group Company Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-08-01	Kingdomway to Set Up 5 Million Yuan Biology Products Joint Venture	MT
24-07-25	Xiamen Kingdomway Unit Sets Up US Joint Venture	MT
24-06-13	Xiamen Kingdomway Group Company(SZSE:002626) dropped from Shenzhen Stock Exchange Component A Share Index	CI
24-06-13	Xiamen Kingdomway Group Company(SZSE:002626) dropped from Shenzhen Stock Exchange Component Index	CI
24-05-22	Xiamen Kingdomway Group Company Approves Cash Dividend for the Year 2023, Payable on 06 June 2024	CI
24-04-29	Xiamen Kingdomway Group Company Proposes Final Cash Dividend for the Year 2023	CI
24-04-29	Xiamen Kingdomway Group Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-29	Xiamen Kingdomway Group Company Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-12	Xiamen Kingdomway Sets Up US Joint Venture	MT
24-02-13	Xiamen Kingdomway to Buy US Nutritional Supplements Firm for $17 Million	MT

Chart Xiamen Kingdomway Group Company

Duration

Period

002626: Dynamic Chart

Xiamen Kingdomway Group Company is a China-based company principally engaged in the production and distribution of nutrition enhancers and health care products. The Company mainly provides coenzyme Q10 series, including coenzyme Q10 lotion and Q10 powder; vitamin A (VA) series, including food level VA acetate, food level VA palmitate, food level VA palmitate powder, food level VA acetate powder, feed level VA powder and feed level VA acetate oil; health products - capsules series, as well as health products - tablets series, among others. The Company distributes its products within domestic market and to overseas markets.

Employees

2,123

Sector

Food Processing

Calendar

Apr. 20 - Q4 2025 Earnings Release

More about the company